Anorectal melanoma [0.03%]
肛门直肠黑色素瘤
Suzanne Fastner,Tina J Hieken,Robert R McWilliams et al.
Suzanne Fastner et al.
Anorectal melanoma is an aggressive mucosal melanoma subtype with a poor prognosis. Although recent advancements have been seen for cutaneous melanoma, the optimal treatment paradigm for management of anorectal melanoma is evolving. In this...
Clinical outcomes and cost of open, laparoscopic, and percutaneous ablation for hepatocellular carcinoma [0.03%]
肝细胞癌开腹、腹腔镜和经皮消融的临床疗效和成本比较研究
Eduardo A Vega,Emeka Agudile,Oscar Salirrosas et al.
Eduardo A Vega et al.
Background: Open (OA), laparoscopic (LA), and percutaneous (PA) ablation are all ablation approaches for hepatocellular carcinoma (HCC) utilized in the United States today. However, it remains unclear today which approach...
Postoperative complications in women with ovarian cancer stratified by cytoreductive surgery outcome [0.03%]
根据初次减瘤手术效果分类的卵巢癌患者的术后并发症
Rosa M Polan,Jennifer M Slota,Emma L Barber
Rosa M Polan
Objective: To compare 30-day postoperative complications for patients with advanced ovarian cancer who underwent resection to no gross residual disease versus optimal and suboptimal cytoreduction. ...
Persistent poverty impacts access to minimally invasive surgery among patients with hepatopancreatobiliary cancer [0.03%]
持久的贫困影响肝胰胆癌患者微创手术的接受度
Karol Rawicz-Pruszyński,Selamawit Woldesenbet,Yutaka Endo et al.
Karol Rawicz-Pruszyński et al.
Background and objectives: Minimally invasive surgery (MIS) has been successfully adopted in hepatopancreatobiliary (HPB) cancer, and has been associated with improved perioperative and comparable oncological outcomes. We...
Response to the Letter to the Editor: Association between sarcopenia and postoperative complications in patients undergoing surgery for gastrointestinal or hepato-pancreatico-biliary cancer [0.03%]
论著答复：癌性恶病质与胃肠及肝胰胆道癌症手术患者术后并发症的关系
Ganesh Nagarajan,Pratik Doshi,Nikhil Bardeskar
Ganesh Nagarajan
Sensitizing medical professionals and caregivers to the palliative surgery's role in cancer care [0.03%]
提高医疗专业人员和护理人员对姑息性手术在癌症治疗中作用的认识
Pallvi Kaul,Pankaj Kumar Garg
Pallvi Kaul
Corrigendum [0.03%]
勘误表
Published Erratum
Journal of surgical oncology. 2023 Sep;128(4):712. DOI:10.1002/jso.27374 2023
Beyond surgical excellence: Unveiling the role of intensive rehabilitation in RIOT for CRS and HIPEC [0.03%]
超越外科手术卓越：揭示RIOT在CRS和HIPEC中强化康复的作用
Amine Souadka,Brahim El Ahmadi
Amine Souadka
Comparison of survival for metastatic pancreatic cancer patients treated with CPI-613 versus resected borderline-resectable pancreatic cancer patients [0.03%]
CPI-613治疗转移性胰腺癌患者与手术切除边缘可切除胰腺癌患者的生存比较
Christopher W Mangieri,Cristian D Valenzuela,Ian B Solsky et al.
Christopher W Mangieri et al.
Introduction: Treatment of advanced pancreatic adenocarcinoma remains suboptimal. Therapeutic agents with a novel mechanism of action are desperately needed; one such novel agent is CPI-613 targets. We here analyze the ou...
Clinical Trial
Journal of surgical oncology. 2023 Oct;128(5):844-850. DOI:10.1002/jso.27365 2023